Latest Beta-lactam Stories
CNIEL, the French National Interprofessional Centre de l’economie Laitiere, has appointed the Charm Science ROSA combination beta-lactam and tetracycline (MRLBLTET) eight minute test as the
Prestigious laboratory validates Charm Sciences’ ROSA One-Minute beta-lactam test in raw, commingled, bovine milk meeting European Union Maximum Residue Limits. Lawrence,
A new paper by a team of University of Notre Dame researchers that included Shahriar Mobashery, Jeffrey Peng, Brian Baker and their researchers Oleg Borbulevych, Malika Kumararasiri, Brian Wilson, Leticia Llarrull, Mijoon Lee, Dusan Hesek and Qicun Shi describes a unique process that is central to induction of antibiotic resistance in the problematic bacterium methicillin-resistant Staphylococcus aureus (MRRA).
A team of scientists from The Scripps Research Institute have successfully reengineered an important antibiotic to kill the deadliest antibiotic-resistant bacteria.
LANSING, Mich., June 6, 2011 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) has received approval from the FDA and National Conference on Interstate Milk Shipments (NCIMS) for its quick and easy BetaStarÂ® Plus assay, developed for use in the United States to detect dairy antibiotic residues, including ceftiofur, in milk.
SEOUL, Korea, May 11, 2011 /PRNewswire/ -- CrystalGenomics, Inc., a biopharmaceutical company with 3 clinical stage candidates, has announced today that the draft Clinical Study Report (CSR) from CG400549's Phase I Multiple Ascending Dose (MAD) Study has just been received. CG400549 is a potential first-in-class antibiotic candidate targeting the fatty acid biosynthesis enzyme FabI, a critical enzyme in generating bacterial membrane and has a novel chemical structure which has never been used...
Experts say that a new superbug could spread throughout the globe that is resistant to even the most powerful antibiotics.
VIENNA, Austria, June 23, 2010 /PRNewswire/ -- EUCODIS Bioscience, a developer and manufacturer of customized enzymes today announced that it has launched a high-performance beta-lactamase designed to inactivate a broad range of beta-lactam antibiotics.
LAKE FOREST, Ill., June 22 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), the world leader in generic injectable pharmaceuticals, today announced it has received U.S. Food and Drug Administration (FDA) approval for meropenem for injection, USP (I.V.) 500 mg and 1 g vials.
Tuberculosis (TB) continues to be a global health problem, in part due to the exceptional drug resistance displayed by the TB-causing agent, Mycobacterium tuberculosis.
- totally perplexed and mixed up.